bit.bio vs Saluda Medical
Side-by-side comparison of AI visibility scores, market position, and capabilities
bit.bio is a Cambridge, UK synthetic biology company using its proprietary opti-ox technology to reprogram stem cells into any human cell type at scale and with high consistency;
About
bit.bio is a synthetic biology company founded in 2016 as a spinout from the Luscher laboratory at the University of Cambridge, headquartered in Cambridge, United Kingdom. The company's core technology platform, opti-ox (optimized overexpression), enables the precise and highly reproducible reprogramming of human induced pluripotent stem cells (iPSCs) into virtually any human cell type — neurons, cardiomyocytes, hepatocytes, immune cells, and more — with a consistency and scalability that has historically been impossible to achieve with conventional differentiation protocols. This precision is achieved by engineering the transcription factor expression cassette into a defined genomic safe harbor site, ensuring every cell in a batch receives the same reprogramming instruction.
Saluda Medical is the pioneer of closed-loop spinal cord stimulation (SCS); FDA-approved Evoke SCS system with real-time neural feedback; raised $100M in Jan 2025; received FDA clearance for automated EVA programming platform.
About
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US operations in Marlborough, Massachusetts), Saluda''s flagship product is the Evoke Spinal Cord Stimulation (SCS) System — the world''s first SCS system that senses and measures neural responses to stimulation (evoked compound action potentials, or ECAPs) and automatically adjusts therapy in real time based on each patient''s neurophysiological feedback. This closed-loop approach provides more precise, consistent pain relief compared to conventional open-loop SCS systems.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.